PH I Addition of Farnesyl Transferase Inhibitor to Temozolomide for Pts w Gr 3 & 4 Malignant Gliomas

Clinical trial NCT00612651 · COMPLETED

Trial details

NCT number: NCT00612651
Sponsor: Duke University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Gliosarcoma Glioblastoma Anaplastic Astrocytoma

Start date: 2005-10-01
Primary completion: 2009-01-01
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.